Antifungal

2019-20 coronavirus outbreak

Emergency medicine

Virology

Dermatology

Medical emergency

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Outbreak

Specialty

Coronavirus disease 2019 (COVID-19)

Candida auris

Family medicine

Infectious disease (medical specialty)

Internal medicine

Medicine

Disease

MMWR Morbidity and Mortality Weekly Report

In July 2020, the Florida Department of Health was alerted to three Candida auris bloodstream infections and one urinary tract infection in four patients with coronavirus disease 2019 (COVID-19) who received care in the same dedicated COVID-19 unit of an acute care hospital (hospital A). C. auris is a multidrug-resistant yeast that can cause invasive infection. Its ability to colonize patients asymptomatically and persist on surfaces has contributed to previous C. auris outbreaks in health care settings (1-7). Since the first C. auris case was identified in Florida in 2017, aggressive measures have been implemented to limit spread, including contact tracing and screening upon detection of a new case. Before the COVID-19 pandemic, hospital A conducted admission screening for C. auris and admitted colonized patients to a separate dedicated ward.

<i>Candida auris</i> Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020

Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020